Differentiation and Phenotyping of Murine Osteoclasts from Bone Marrow Progenitors, Monocytes, and Dendritic Cells

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2021 May 31

PMID 34057711

Citations 4

Authors

Julia Halper

Maria-Bernadette Madel

Claudine Blin-Wakkach

Affiliations

Soon will be listed here.

Abstract

Bone physiology is dictated by various players, including osteoclasts (OCLs) as bone resorbing cells, osteoblasts (capable of bone formation), osteocytes, or mesenchymal stem cells, to mention the most important players. All these cells are in tight communication with each other and influence the constantly occurring process of bone remodeling to meet changing requirements on the skeletal system. In order to understand these interplays, one must investigate isolated functions of the various cell types. However, OCL research displays a special drawback: due to their giant size, low abundance, and tight attachment on the bone surface, ex vivo isolation of sufficient amounts of mature OCLs is limited or not conceivable in most species including mice. Moreover, OCLs can be obtained from different progenitors in vivo as well as in vitro. Thus, in vitro differentiation of OCLs from various progenitor cells remains essential in the analysis of OCL biology, underlining the importance of reliable gold standard protocols to be applied throughout OCL research. This chapter will deal with in vitro differentiation of OCLs from murine bone marrow cells, as well as isolated monocytes and dendritic cells that have already been validated in numerous studies.

Citing Articles

A novel proteomic signature of osteoclast differentiation unveils the deubiquitinase UCHL1 as a necessary osteoclastogenic driver.

Materozzi M, Resnati M, Facchi C, Trudu M, Orfanelli U, Perini T Sci Rep. 2024; 14(1):7290.

PMID: 38538704 PMC: 10973525. DOI: 10.1038/s41598-024-57898-y.

Omega-3 PUFAs prevent bone impairment and bone marrow adiposity in mouse model of obesity.

Benova A, Ferencakova M, Bardova K, Funda J, Prochazka J, Spoutil F Commun Biol. 2023; 6(1):1043.

PMID: 37833362 PMC: 10575870. DOI: 10.1038/s42003-023-05407-8.

Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast CNCM I-745 reduces bone loss in osteoporosis.

Madel M, Halper J, Ibanez L, Claire L, Rouleau M, Boutin A Elife. 2023; 12.

PMID: 36848406 PMC: 9977286. DOI: 10.7554/eLife.82037.

Inhibition of Notch Signaling Stimulates Osteoclastogenesis From the Common Trilineage Progenitor Under Inflammatory Conditions.

Filipovic M, Flegar D, Sucur A, Sisl D, Kavazovic I, Antica M Front Immunol. 2022; 13:902947.

PMID: 35865541 PMC: 9294223. DOI: 10.3389/fimmu.2022.902947.

References

Charles J, Aliprantis A . Osteoclasts: more than 'bone eaters'. Trends Mol Med. 2014; 20(8):449-59. PMC: 4119859. DOI: 10.1016/j.molmed.2014.06.001. View

Madel M, Ibanez L, Wakkach A, de Vries T, Teti A, Apparailly F . Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions. Front Immunol. 2019; 10:1408. PMC: 6594198. DOI: 10.3389/fimmu.2019.01408. View

Jacome-Galarza C, Lee S, Lorenzo J, Aguila H . Identification, characterization, and isolation of a common progenitor for osteoclasts, macrophages, and dendritic cells from murine bone marrow and periphery. J Bone Miner Res. 2012; 28(5):1203-13. PMC: 3625454. DOI: 10.1002/jbmr.1822. View

Wakkach A, Mansour A, Dacquin R, Coste E, Jurdic P, Carle G . Bone marrow microenvironment controls the in vivo differentiation of murine dendritic cells into osteoclasts. Blood. 2008; 112(13):5074-83. DOI: 10.1182/blood-2008-01-132787. View

Walker D . Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through use of bone marrow and splenic transplants. J Exp Med. 1975; 142(3):651-63. PMC: 2189929. DOI: 10.1084/jem.142.3.651. View

Yahara Y, Barrientos T, Tang Y, Puviindran V, Nadesan P, Zhang H . Erythromyeloid progenitors give rise to a population of osteoclasts that contribute to bone homeostasis and repair. Nat Cell Biol. 2020; 22(1):49-59. PMC: 6953622. DOI: 10.1038/s41556-019-0437-8. View

Horwood N, Elliott J, Martin T, Gillespie M . Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology. 1998; 139(11):4743-6. DOI: 10.1210/endo.139.11.6433. View

Simonet W, Lacey D, Dunstan C, Kelley M, Chang M, Luthy R . Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997; 89(2):309-19. DOI: 10.1016/s0092-8674(00)80209-3. View

Takahashi N, Yamana H, Yoshiki S, Roodman G, Mundy G, Jones S . Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology. 1988; 122(4):1373-82. DOI: 10.1210/endo-122-4-1373. View

10.

Arron J, Choi Y . Bone versus immune system. Nature. 2000; 408(6812):535-6. DOI: 10.1038/35046196. View

11.

Ciucci T, Ibanez L, Boucoiran A, Birgy-Barelli E, Pene J, Abou-Ezzi G . Bone marrow Th17 TNFα cells induce osteoclast differentiation, and link bone destruction to IBD. Gut. 2014; 64(7):1072-81. DOI: 10.1136/gutjnl-2014-306947. View

12.

Kong Y, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S . Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999; 402(6759):304-9. DOI: 10.1038/46303. View

13.

Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y . Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006; 203(12):2673-82. PMC: 2118166. DOI: 10.1084/jem.20061775. View

14.

Zaiss M, Axmann R, Zwerina J, Polzer K, Guckel E, Skapenko A . Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum. 2007; 56(12):4104-12. DOI: 10.1002/art.23138. View

15.

Ibanez L, Abou-Ezzi G, Ciucci T, Amiot V, Belaid N, Obino D . Inflammatory Osteoclasts Prime TNFα-Producing CD4 T Cells and Express CX CR1. J Bone Miner Res. 2016; 31(10):1899-1908. DOI: 10.1002/jbmr.2868. View

16.

de Vries T, El Bakkali I, Kamradt T, Schett G, Jansen I, DAmelio P . What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss?. Front Immunol. 2019; 10:505. PMC: 6434996. DOI: 10.3389/fimmu.2019.00505. View

17.

Madel M, Ibanez L, Ciucci T, Halper J, Rouleau M, Boutin A . Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of . Elife. 2020; 9. PMC: 7220377. DOI: 10.7554/eLife.54493. View

18.

Kiesel J, Buchwald Z, Aurora R . Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. J Immunol. 2009; 182(9):5477-87. DOI: 10.4049/jimmunol.0803897. View

19.

Cappariello A, Maurizi A, Veeriah V, Teti A . The Great Beauty of the osteoclast. Arch Biochem Biophys. 2014; 558:70-8. DOI: 10.1016/j.abb.2014.06.017. View

20.

Li H, Hong S, Qian J, Zheng Y, Yang J, Yi Q . Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells. Blood. 2010; 116(2):210-7. PMC: 2910608. DOI: 10.1182/blood-2009-11-255026. View